Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT. Overgaard M, et al. Among authors: mouridsen ht. Lancet. 1999 May 15;353(9165):1641-8. doi: 10.1016/S0140-6736(98)09201-0. Lancet. 1999. PMID: 10335782 Clinical Trial.
Endocrine management of advanced breast cancer.
Rose C, Mouridsen HT. Rose C, et al. Among authors: mouridsen ht. Horm Res. 1989;32 Suppl 1:189-96; discussion 197. doi: 10.1159/000181344. Horm Res. 1989. PMID: 2693326 Review.
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K. Overgaard M, et al. Among authors: mouridsen ht. N Engl J Med. 1997 Oct 2;337(14):949-55. doi: 10.1056/NEJM199710023371401. N Engl J Med. 1997. PMID: 9395428 Free article. Clinical Trial.
Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer--a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group. Danish Breast Cancer Cooperative Group (DBCG).
Andersson M, Madsen EL, Overgaard M, Rose C, Dombernowsky P, Mouridsen HT. Andersson M, et al. Among authors: mouridsen ht. Eur J Cancer. 1999 Jan;35(1):39-46. doi: 10.1016/s0959-8049(98)00354-2. Eur J Cancer. 1999. PMID: 10211086 Clinical Trial.
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age.
Rose C, Kamby C, Mouridsen HT, Andersson M, Bastholt L, Møller KA, Andersen J, Munkholm P, Dombernowsky P, Christensen IJ. Rose C, et al. Among authors: mouridsen ht. Breast Cancer Res Treat. 2000 May;61(2):103-10. doi: 10.1023/a:1006460925986. Breast Cancer Res Treat. 2000. PMID: 10942095 Clinical Trial.
Improved outcome from substituting methotrexate with epirubicin: results from a randomised comparison of CMF versus CEF in patients with primary breast cancer.
Ejlertsen B, Mouridsen HT, Jensen MB, Andersen J, Cold S, Edlund P, Ewertz M, Jensen BB, Kamby C, Nordenskjold B, Bergh J. Ejlertsen B, et al. Among authors: mouridsen ht. Eur J Cancer. 2007 Mar;43(5):877-84. doi: 10.1016/j.ejca.2007.01.009. Epub 2007 Feb 16. Eur J Cancer. 2007. PMID: 17306974 Clinical Trial.
334 results